Asa SL - Search Results

1

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Rindi G, et al. Among authors: asa sl. Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16. Endocr Pathol. 2022. PMID: 35294740 Review.

2

Clonality of thyroid nodules in sporadic goiter.

Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL. Apel RL, et al. Among authors: asa sl. Diagn Mol Pathol. 1995 Jun;4(2):113-21. doi: 10.1097/00019606-199506000-00007. Diagn Mol Pathol. 1995. PMID: 7551291

3

Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings.

Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. Thodou E, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1995 Aug;80(8):2302-11. doi: 10.1210/jcem.80.8.7629223. J Clin Endocrinol Metab. 1995. PMID: 7629223

4

Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells.

Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL. Ezzat S, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1995 Feb;80(2):534-9. doi: 10.1210/jcem.80.2.7852516. J Clin Endocrinol Metab. 1995. PMID: 7852516

5

Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

Ezzat S, Smyth HS, Ramyar L, Asa SL. Ezzat S, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1995 Mar;80(3):878-84. doi: 10.1210/jcem.80.3.7883846. J Clin Endocrinol Metab. 1995. PMID: 7883846

6

Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.

Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvath E, Kovacs K, Frohman LA. Ezzat S, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1994 Mar;78(3):555-60. doi: 10.1210/jcem.78.3.8126126. J Clin Endocrinol Metab. 1994. PMID: 8126126

7

Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.

Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. Zafar M, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1995 Dec;80(12):3621-7. doi: 10.1210/jcem.80.12.8530610. J Clin Endocrinol Metab. 1995. PMID: 8530610

8

Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.

LeRiche VK, Asa SL, Ezzat S. LeRiche VK, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1996 Feb;81(2):656-62. doi: 10.1210/jcem.81.2.8636285. J Clin Endocrinol Metab. 1996. PMID: 8636285

9

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S, Asa SL. Sugg SL, et al. Among authors: asa sl. J Clin Endocrinol Metab. 1996 Sep;81(9):3360-5. doi: 10.1210/jcem.81.9.8784097. J Clin Endocrinol Metab. 1996. PMID: 8784097

10

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL. Ezzat S, et al. Among authors: asa sl. Thyroid. 1996 Oct;6(5):409-16. doi: 10.1089/thy.1996.6.409. Thyroid. 1996. PMID: 8936664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

633 results

Search Page

Filters